Pharmalancers Ltd 13630562 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is Global Online Platform for Independant Life Sciences Consultants Digita Accounts Production Advanced 6.30.9574.0 true 13630562 2023-04-01 2024-03-31 13630562 2024-03-31 13630562 core:CurrentFinancialInstruments 2024-03-31 13630562 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 13630562 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 13630562 bus:SmallEntities 2023-04-01 2024-03-31 13630562 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 13630562 bus:AbridgedAccounts 2023-04-01 2024-03-31 13630562 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 13630562 bus:RegisteredOffice 2023-04-01 2024-03-31 13630562 bus:Director1 2023-04-01 2024-03-31 13630562 bus:Director2 2023-04-01 2024-03-31 13630562 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 13630562 countries:UnitedKingdom 2023-04-01 2024-03-31 13630562 2022-04-01 2023-03-31 13630562 2023-03-31 13630562 core:CurrentFinancialInstruments 2023-03-31 13630562 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 13630562 core:Non-currentFinancialInstruments core:AfterOneYear 2023-03-31 iso4217:GBP xbrli:pure

Registration number: 13630562

Pharmalancers Ltd

Annual Report and Unaudited Abridged Financial Statements

for the Year Ended 31 March 2024

 

Pharmalancers Ltd

Contents

Company Information

1

Directors' Report

2

Abridged Balance Sheet

3 to 4

Notes to the Unaudited Abridged Financial Statements

5

 

Pharmalancers Ltd

Company Information

Directors

Shalabh Kumar

Angela Potts

Registered office

Ashcombe House
5 The Crescent
Leatherhead
Surrey
KT22 8DY

Accountants

Quartier Ltd
7 Becket Wood
Newdigate
Dorking
Surrey
RH5 5AQ

 

Pharmalancers Ltd

Directors' Report for the Year Ended 31 March 2024

The directors present their report and the abridged financial statements for the year ended 31 March 2024.

Directors of the company

The directors who held office during the year were as follows:

Shalabh Kumar

Angela Potts

Principal activity

The principal activity of the company is Global Online Platform for Independant Life Sciences Consultants

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the Board on 20 September 2024 and signed on its behalf by:
 

.........................................
Shalabh Kumar
Director

 

Pharmalancers Ltd

(Registration number: 13630562)
Abridged Balance Sheet as at 31 March 2024

Note

2024
£

2023
£

Fixed assets

 

Intangible assets

14,120

16,126

Current assets

 

Debtors

9,704

4,320

Cash at bank and in hand

 

13,404

9,711

 

23,108

14,031

Prepayments and accrued income

 

22,105

-

Creditors: Amounts falling due within one year

(6,590)

(1,933)

Net current assets

 

38,623

12,098

Total assets less current liabilities

 

52,743

28,224

Creditors: Amounts falling due after more than one year

(15,537)

(13,545)

Accruals and deferred income

 

(23,058)

(1,140)

Net assets

 

14,148

13,539

Capital and reserves

 

Called up share capital

30,000

30,000

Retained earnings

(15,852)

(16,461)

Shareholders' funds

 

14,148

13,539

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 20 September 2024 and signed on its behalf by:
 

 

Pharmalancers Ltd

(Registration number: 13630562)
Abridged Balance Sheet as at 31 March 2024

.........................................
Shalabh Kumar
Director

 

Pharmalancers Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

1

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).